Arkolith/Insider Trading/CATX/Form 4

Austin Mark John

VP Finance/Prin Fin&Acct OfficPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Apr 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2024Option exercise(M)30K$0.36$11K84K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 23, 2024Option exercise(M)30K—$0120K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-047645) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML